15 Jul, 2020

John Lyle, PhD

Dr. Lyle joined Personalis in 2020 to manage the company’s assay research and development efforts.  Prior to assuming this role, he spent 14 years at Pacific Biosciences where he most recently served as Senior Director of Single Molecule Sequencing focusing on reagent, system, and application development of long-read, ultra-high accuracy sequencing. Dr. Lyle received his [...]

17 Apr, 2020

Stephen Moore, JD

Stephen Moore joined Personalis as General Counsel in April 2020, with more than twenty years in-house legal experience at advanced genomics companies. Prior to joining Personalis, he was General Counsel at Pacific Biosciences, a publicly listed company and pioneer in the field of single molecule, long read DNA sequencing, where he worked for over a [...]

6 Nov, 2019

Rena McClory, PhD

Rena McClory joined Personalis in 2014, and serves as Vice President, Marketing, where she established and leads marketing and product management teams in building brands and accelerating product adoption in key immune-oncology, basic research and clinical markets. She was promoted from Senior Director, Cancer Research and Clinical Services in 2015. Rena brings over 20 years [...]

1 Apr, 2019

Aaron Tachibana

Aaron Tachibana joined Personalis as Chief Financial Officer in March 2019, with more than fifteen years of executive financial management experience at large, medium, and small cap public and private companies. Prior to Personalis, Mr. Tachibana was Chief Financial Officer at Lumentum from August 2015 to September 2018.  Lumentum is a publicly listed optical and [...]

6 Nov, 2017

Stephane Mouradian, PhD

Stephane leads the Business Development team at Personalis. Previously, Stephane was at Illumina where he led Illumina’s companion diagnostic partnerships with pharmaceutical companies in oncology, the international expansion of NIPT (Non Invasive Prenatal Testing) and Illumina’s venture investments in start-ups such as Twist (synthetic biology) and Boreal Genomics (liquid biopsy), for which he served as [...]

5 Sep, 2017

Xavier Paliard, Pharm.D., Ph.D.

Xavier Paliard joined Personalis in July 2017 as Vice President Immunology, Research & Development where he leads the strategy as well as R&D in the area of personalized cancer vaccines and other personalized therapeutic opportunities. He has over 25 years of experience in Research & Development of vaccines, biologics and small molecules across an array [...]

31 Aug, 2017

Lloyd Hsu

Lloyd Hsu joined Personalis in May 2015 as VP of Software Engineering. Mr. Hsu owns and drives all aspects of software development, architecture and strategy. Mr. Hsu also leads the IT department and is responsible for ensuring the IT infrastructure aligns with Personalis’ business strategy. Prior to this role, Mr. Hsu spent 4 years as [...]

19 Aug, 2017

Carol J. Tillis

Carol J. Tillis joined Personalis in November 2011 with over 20 years of experience in senior financial management, much of it related to DNA sequencing. From 2004 to 2010, she was Vice President of Finance at Pacific Biosciences, Inc. Ms. Tillis started at Pacific Biosciences as its first full-time finance person during the company’s early [...]

19 Aug, 2017

Christian Haudenschild, PhD

Dr. Haudenschild joined Personalis in early 2012 to build the company’s professional services department. Prior to this role he was an Associate Director in charge of commercial sequencing at Illumina Inc. in Hayward, California. His team was responsible for the preparation and next-generation sequencing of thousands of DNA and RNA samples. Dr. Haudenschild was previously [...]

Go to Top